Revision as of 11:16, 7 September 2023

The "How I Treat" series has been published by Blood for several decades and covers a wide variety of topics in malignant and classical hematology. While these articles are not considered to be formal guidelines, they are considered high-level expert opinion. They cover topics ranging from commonly encountered hematologic conditions with a large evidence base, to very rare conditions with only case reports to guide treatment. The purpose of this page is to consolidate the links to all known published How I Treat articles.

Articles are presented by condition, in reverse chronological order. Given the rapid change in evidence in many areas of hematology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.

Note: this page is currently under construction.

Malignant hematology

Myeloid neoplasms

Lymphoid neoplasms

Adult T-cell leukemia-lymphoma (ATLL)

2021: Cook & Phillips How I treat adult T-cell leukemia/lymphoma PubMed

Chronic lymphocytic leukemia (CLL/SLL)

2021: Lew et al. How I treat chronic lymphocytic leukemia after venetoclax
2019: Stephens & Byrd. How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia
2018: Brown. How I treat CLL patients with ibrutinib PubMed

Cutaneous T-cell lymphoma (CTCL)

2019: Shinohara & Shustov How I treat primary cutaneous CD30 + lymphoproliferative disorders

Hodgkin lymphoma

2021: Epperla & Herrera How I incorporate novel agents into the treatment of classical Hodgkin lymphoma
2020: Eichenauer & Engert How I treat nodular lymphocyte-predominant Hodgkin Lymphoma

Diffuse large B-cell lymphoma (DLBCL)

2023: Lugtenburg & Mutsaers How I treat older patients with DLBCL in the frontline setting PubMed

Follicular lymphoma (FL)

2019: Casulo & Barr How I treat early-relapsing follicular lymphoma PubMed

=Large granular lymphocytic leukemia (T-LGL)

2011: Lamy & Loughran. How I treat LGL leukemia PubMed

NK- and T-cell lymphoma

2013: Tse & Kwong How I treat NK/T-cell lymphomas PubMed

Prolymphocytic leukemia (T-PLL)

2012: Dearden How I treat prolymphocytic leukemia PubMed

Waldenström macroglobulinemia (WM)

2019: Dimopoulos & Kastritis. How I treat Waldenström macroglobulinemia PubMed

Plasma cell dyscrasias

Light-chain (AL) amyloidosis

2022: Palladini & Merlini How I treat AL amyloidosis

Multiple myeloma

2023: van de Donk How We Manage Newly Diagnosed Multiple Myeloma With Circulating Tumor Cells
2022: Zamagni et al. How I treat high-risk multiple myeloma
2022: Kastritis et al. How I treat relapsed multiple myeloma
2022: Vaxman & Gertz How I approach smoldering multiple myeloma

Histiocytic disorders

Classical hematology

Complications of treatment

@@ Line 58: / Line 58: @@
 ===[[Follicular lymphoma|Follicular lymphoma (FL)]]===
 *'''2019:''' Casulo & Barr [https://doi.org/10.1182/blood-2018-08-822148 How I treat early-relapsing follicular lymphoma] [https://pubmed.ncbi.nlm.nih.gov/30700421/ PubMed]
+===[[Large granular lymphocytic leukemia|Large granular lymphocytic leukemia (T-LGL)]]==
+*'''2011:''' Lamy & Loughran. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062292/ How I treat LGL leukemia] [https://pubmed.ncbi.nlm.nih.gov/21190991/ PubMed]
 ===[[NK- and T-cell lymphoma]]===
 *'''2013:''' Tse & Kwong [http://www.bloodjournal.org/content/121/25/4997.long How I treat NK/T-cell lymphomas] [https://pubmed.ncbi.nlm.nih.gov/23652805/ PubMed]
+===[[T-cell prolymphocytic leukemia|Prolymphocytic leukemia (T-PLL)]]===
+*'''2012:''' Dearden [https://doi.org/10.1182/blood-2012-01-380139 How I treat prolymphocytic leukemia] [https://pubmed.ncbi.nlm.nih.gov/22649104/ PubMed]
 ===[[Waldenström macroglobulinemia|Waldenström macroglobulinemia (WM)]]===

Difference between revisions of "How I Treat"